EMILY OSTRANDER: Open Payments
NPI 1831556323 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 32 payments from 13 companies in 2025. Trend: 2023 $1,176 · 2024 $907 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $180 |
| Novartis Pharmaceuticals Corporation | 5 | $98 |
| Boston Scientific Corporation | 4 | $77 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $61 |
| Novo Nordisk Inc | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: VERQUVO, LEQVIO, WATCHMAN FLX, LifeVest, Wegovy, CAPVAXIVE, PASCAL, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across KS — which companies pay providers there.
